Jasper Therapeutics (JSPR)

• Market cap: $67M
• 1 day: -7.85%
• 5 days: -15.85%
• 1 month: -24.79%
• 3 months: -78.71%
• 6 months: -76.29%
• Year to date: -78.85%
• 1 year: -84.81%
• 5 years: -96.37%
• 10 years: -96.37%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

147% more call options, than puts

Call options by funds: $6.82M | Put options by funds: $2.76M

100% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 16

58% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 12

22% more capital invested

Capital invested by funds: $275M [Q3] → $334M (+$59.4M) [Q4]

8% more funds holding

Funds holding: 79 [Q3] → 85 (+6) [Q4]

7.06% more ownership

Funds ownership: 97.24% [Q3] → 104.31% (+7.06%) [Q4]

25% less funds holding in top 10

Funds holding in top 10: 4 [Q3] → 3 (-1) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $38 752% upside
• Avg. target: $49 999% upside
• High target: $70 1,470% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Emily Bodnar 21% 1-year accuracy 34 / 162 met price target	797% upside $40	Buy Reiterated	11 Mar 2025
UBS Trung Huynh 43% 1-year accuracy 3 / 7 met price target	752% upside $38	Buy Initiated	13 Feb 2025
JMP Securities Silvan Tuerkcan 23% 1-year accuracy 12 / 53 met price target	1,470% upside $70	Market Outperform Reiterated	10 Jan 2025
RBC Capital Gregory Renza 32% 1-year accuracy 24 / 75 met price target	976% upside $48	Outperform Maintained	9 Jan 2025